Middle East Pharmaceutical Industries Co. (4016)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

News

4 February 11:16 AM Avalon Pharma, Bio-Thera reach license agreements for BAT3306 in MENA

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with Bio-Thera Solutions to register Pembrolizumab in Saudi Arabia and MENA markets Under the agreement, …

Global Economy

13 April 2025 09:30 AM Avalon Pharma unveils SAR 25m cash dividends for H2-24

Riyadh – Mubasher: The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million for the second half (H2) of 2024, according to a bourse filing. The Saudi group will disburse SAR 1.25 …

Cash Dividends

31 July 2024 11:58 AM Avalon Pharma’s board approves dividends for H1-24

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) is set to disburse cash dividends worth SAR 15 million, equivalent to 7.50% of the capital, for the first half (H1) of 2024. Avalon Pharma will pay out a dividend of …

Board of Directors

9 July 2024 11:49 AM Avalon Pharma obtains SAR 70m from Emirates NBD

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) secured a Sharia facility amounting to SAR 70 million from Emirates NBD on 8 July 2024. The Saudi company obtained the loan for one year to finance its operations, …

Banking and Finance